BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 31087810)

  • 1. Fluid Biomarkers in Individuals at Risk for Genetic Prion Disease up to Disease Conversion.
    Vallabh SM; Mortberg MA; Allen SW; Kupferschmid AC; Kivisakk P; Hammerschlag BL; Bolling A; Trombetta BA; Devitte-McKee K; Ford AM; Sather LE; Duffy G; Rivera A; Gerber J; McManus AJ; Minikel EV; Arnold SE
    Neurology; 2024 Jul; 103(2):e209506. PubMed ID: 38896810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased CX3CL1 in cerebrospinal fluid and ictal serum t-tau elevations in migraine: results from a cross-sectional exploratory case-control study.
    Süße M; Kloetzer C; Strauß S; Ruhnau J; Overeem LH; Bendig M; Schulze J; Reuter U; Vogelgesang A; Fleischmann R
    J Headache Pain; 2024 Apr; 25(1):46. PubMed ID: 38561692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum tau protein elevation in migraine: a cross-sectional case-control study.
    Overeem LH; Raffaelli B; Fleischmann R; Süße M; Vogelgesang A; Maceski AM; Papadopoulou A; Ruprecht K; Su W; Koch M; Siebert A; Arkuszewski M; Tenenbaum N; Kuhle J; Reuter U
    J Headache Pain; 2023 Sep; 24(1):130. PubMed ID: 37726712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence for neuronal damage or astrocytic activation in cerebrospinal fluid of Neuro-COVID-19 patients with long-term persistent headache.
    de Boni L; Odainic A; Gancarczyk N; Kaluza L; Strassburg CP; Kersting XAK; Wüllner U; Schmidt SV; Petzold GC
    Neurol Res Pract; 2023 Sep; 5(1):49. PubMed ID: 37759276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF, Blood, and MRI Biomarkers in Skogholt's Disease-A Rare Neurodegenerative Disease in a Norwegian Kindred.
    Aspli KT; Aaseth JO; Holmøy T; Blennow K; Zetterberg H; Kirsebom BE; Fladby T; Selnes P
    Brain Sci; 2023 Oct; 13(11):. PubMed ID: 38002473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: New cerebrospinal fluid research to uncover mechanisms driving neurological and psychiatric diseases, volume II.
    Skripuletz T; Torkildsen Ø
    Front Neurol; 2023; 14():1346377. PubMed ID: 38148983
    [No Abstract]   [Full Text] [Related]  

  • 7. Functional brain activity constrained by structural connectivity reveals cohort-specific features for serum neurofilament light chain.
    Sihag S; Naze S; Taghdiri F; Gumus M; Tator C; Green R; Colella B; Blennow K; Zetterberg H; Dominguez LG; Wennberg R; Mikulis DJ; Tartaglia MC; Kozloski JR
    Commun Med (Lond); 2022; 2():8. PubMed ID: 35603281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression.
    Michel M; Fiebich BL; Kuzior H; Meixensberger S; Berger B; Maier S; Nickel K; Runge K; Denzel D; Pankratz B; Schiele MA; Domschke K; van Elst LT; Endres D
    Transl Psychiatry; 2021 May; 11(1):308. PubMed ID: 34021122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid markers in neurological disorders.
    Massaro AR; Scivoletto G; Tonali P
    Ital J Neurol Sci; 1990 Dec; 11(6):537-47. PubMed ID: 1707039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofilament light chain as a biomarker in neurological disorders.
    Gaetani L; Blennow K; Calabresi P; Di Filippo M; Parnetti L; Zetterberg H
    J Neurol Neurosurg Psychiatry; 2019 Aug; 90(8):870-881. PubMed ID: 30967444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid biomarkers in patients with neurological symptoms but without neurological diseases.
    Constantinescu R; Mahamud U; Constantinescu C; Eriksson B; Novakova L; Olsson B; Rosengren L; Blennow K; Axelsson M
    Acta Neurol Scand; 2019 Sep; 140(3):177-183. PubMed ID: 31087810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
    Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
    Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis.
    Gavhed D; Akefeldt SO; Osterlundh G; Laurencikas E; Hjorth L; Blennow K; Rosengren L; Henter JI
    Pediatr Blood Cancer; 2009 Dec; 53(7):1264-70. PubMed ID: 19688833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid brain injury biomarkers in children: a multicenter study.
    Shahim P; Darin N; Andreasson U; Blennow K; Jennions E; Lundgren J; Månsson JE; Naess K; Törnhage CJ; Zetterberg H; Mattsson N
    Pediatr Neurol; 2013 Jul; 49(1):31-39.e2. PubMed ID: 23827424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-neurological surgery and cerebrospinal fluid biomarkers for neuronal and astroglial integrity.
    Anckarsäter R; Anckarsäter H; Bromander S; Blennow K; Wass C; Zetterberg H
    J Neural Transm (Vienna); 2014 Jun; 121(6):649-53. PubMed ID: 24420082
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.